The Long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy

Joanna E. Fardell, Janette Vardy, Lauren A. Monds, Ian N. Johnston

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


Chemotherapy treatment is associated with cognitive dysfunction in cancer survivors after treatment completion. The duration of these impairments is unclear. Therefore this paper aims to evaluate the lasting impact of varying doses of the chemotherapy oxaliplatin (OX) on cognition and peripheral neuropathy. In Experiment 1 rats were treated once a week for 3 weeks with either physiological saline (control) or 6. mg/kg OX i.p. and were assessed for peripheral neuropathy, using von Frey filaments, and cognitive function, using novel object and location recognition, up to 2 weeks after treatment completion. For Experiment 2 rats received 3 weekly i.p. injections of either physiological saline (control), 0.6. mg/kg, 2. mg/kg or 6. mg/kg OX and assessed for peripheral neuropathy and cognitive function up to 11 months after treatment completion. Systemic OX treatment induced lasting effects on cognitive function at 11 months after treatment, and peripheral neuropathy at 1 month after treatment and these were dose dependent; higher doses of OX resulted in worse cognitive outcomes and more severe peripheral neuropathy.
Original languageEnglish
Pages (from-to)80-88
Number of pages9
JournalBehavioural Brain Research
Publication statusPublished - 15 Sept 2015
Externally publishedYes


  • oxaliplatin
  • chemotherapy
  • cognition
  • rat
  • peripheral neuropathy
  • mechanical allodynia


Dive into the research topics of 'The Long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy'. Together they form a unique fingerprint.

Cite this